MODULATION OF HALLMARKS OF GLIOBLASTOMA MULTIFORME BY BIOACTIVE PHYTOCHEMICALS: A PRECLINICAL MECHANISTIC EVALUATION

被引：0
|
作者：
Bobak, Adam [1 ]
Steves, Michael [1 ]
Mcmahon, Emily [1 ]
Spahiu, Matea [1 ]
Rahman, Austin [1 ]
Casarcia, Nicolette [1 ]
Bishayee, Anupam [1 ]
机构：
[1] Lake Erie Coll Osteopath Med, Bradenton, FL 34211 USA
来源：
NEURO-ONCOLOGY | 2024年 / 26卷
关键词：
D O I：
10.1093/neuonc/noae165.0281
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CSIG-32.
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Preclinical evaluation of bafetinib for treatment of glioblastoma multiforme.
    Veicheti, V.
    Peterson, B.
    Levitt, D.
    Prakash, O.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [2] Preclinical Evaluation of Radiolabeled Peptides for PET Imaging of Glioblastoma Multiforme
    Novy, Zbynek
    Stepankova, Jana
    Hola, Michaela
    Flasarova, Dominika
    Popper, Miroslav
    Petrik, Milos
    MOLECULES, 2019, 24 (13):
  • [3] Recent updates on the role of phytochemicals in the treatment of glioblastoma multiforme
    Sharma, Pramita
    Mondal, Himel
    Mondal, Shaikat
    Majumder, Rabindranath
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2023, 19 : S513 - S522
  • [4] Recent updates on the role of phytochemicals in the treatment of glioblastoma multiforme
    Sharma, Pramita
    Mondal, Himel
    Mondal, Shaikat
    Majumder, Rabindranath
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2023, 19 (SUPPL 2) : S513 - S522
  • [5] Preclinical evaluation of ex vivo expanded/activated γδ T cells for immunotherapy of glioblastoma multiforme
    Bryant, Nichole L.
    Gillespie, G. Yancey
    Lopez, Richard D.
    Markert, James M.
    Cloud, Gretchen A.
    Langford, Catherine P.
    Arnouk, Hilal
    Su, Yun
    Haines, Hilary L.
    Suarez-Cuervo, Catalina
    Lamb, Lawrence S., Jr.
    JOURNAL OF NEURO-ONCOLOGY, 2011, 101 (02) : 179 - 188
  • [6] Preclinical evaluation of ex vivo expanded/activated γδ T cells for immunotherapy of glioblastoma multiforme
    Nichole L. Bryant
    G. Yancey Gillespie
    Richard D. Lopez
    James M. Markert
    Gretchen A. Cloud
    Catherine P. Langford
    Hilal Arnouk
    Yun Su
    Hilary L. Haines
    Catalina Suarez-Cuervo
    Lawrence S. Lamb
    Journal of Neuro-Oncology, 2011, 101 : 179 - 188
  • [7] Preclinical and clinical advances to overcome hypoxia in glioblastoma multiforme
    Bou-Gharios, Jolie
    Noel, Georges
    Burckel, Helene
    CELL DEATH & DISEASE, 2024, 15 (07):
  • [8] Immunotherapy and Epigenetic Pathway Modulation in Glioblastoma Multiforme
    Chin, Christopher
    Lunking, Emma S.
    de la Fuente, Macarena
    Ayad, Nagi G.
    FRONTIERS IN ONCOLOGY, 2018, 8
  • [9] Preclinical and clinical implications of TERT promoter mutation in glioblastoma multiforme
    Jeong, Da Eun
    Woo, Seon Rang
    Nam, Hyun
    Nam, Do-Hyun
    Lee, Jae-Ho
    Joo, Kyeung Min
    ONCOLOGY LETTERS, 2017, 14 (06) : 8213 - 8219
  • [10] Preclinical research reveals biomarker of tumor response in glioblastoma multiforme
    不详
    FUTURE ONCOLOGY, 2009, 5 (07) : 928 - 928
12345